Cardiac Surgery News and Research RSS Feed - Cardiac Surgery News and Research

New ESC Guidelines on infective endocarditis support role of imaging in diagnosis

New ESC Guidelines on infective endocarditis support role of imaging in diagnosis

ESC Guidelines published today on infective endocarditis boost the role of imaging in diagnosis of this deadly disease. [More]
First patient enrolled in CSL Behring's rVIIa-FP Phase II/III study to treat patients with hemophilia A or B with inhibitors

First patient enrolled in CSL Behring's rVIIa-FP Phase II/III study to treat patients with hemophilia A or B with inhibitors

CSL Behring announced today that the first patient has been enrolled in its Phase II/III clinical study evaluating the pharmacokinetics (PK), efficacy, and safety of the company's recombinant fusion protein linking coagulation factor VIIa with albumin (rVIIa-FP) for on-demand treatment in patients with congenital hemophilia A or B who have developed an inhibitor to factor VIII or factor IX replacement therapy. [More]
Cyberonics, Sorin provide update on pending business combination

Cyberonics, Sorin provide update on pending business combination

Cyberonics, Inc. and Sorin S.p.A. today announced an update on various matters relating to their pending business combination (the "Transaction"). [More]
Seizures are common but not clinically apparent in newborns after cardiac surgery

Seizures are common but not clinically apparent in newborns after cardiac surgery

In 2011, the American Clinical Neurophysiology Society issued a guideline recommending that neonates undergoing cardiac surgery for repair of congenital heart disease be placed on continuous encephalographic (EEG) monitoring after surgery to detect seizures. These recommendations followed reports that seizures are common in this population, may not be detected clinically, and are associated with adverse neurocognitive outcomes. [More]
Arterial shunt in hybrid palliation better for hypoplastic left heart syndrome treatment

Arterial shunt in hybrid palliation better for hypoplastic left heart syndrome treatment

Children born with the major congenital heart defect hypoplastic left heart syndrome (HLHS) often must undergo a series of corrective surgeries beginning at birth. While most have the standard three-stage Norwood procedure, a hybrid strategy has been introduced to offset some disadvantages associated with the Norwood surgeries. In a report in The Journal of Thoracic and Cardiovascular Surgery, investigators compare whether outcomes can be improved if an arterial shunt is used as a source of pulmonary blood flow rather than the more conventional venous shunt as part of the hybrid strategy of HLHS surgical reconstruction. [More]

Health Canada approves Sorin’s Perceval sutureless aortic valve

Sorin Group, a global medical device company and a leader in the treatment of cardiovascular diseases, today announced the Canadian approval of its Perceval sutureless aortic valve. [More]

New set of clinical practice guidelines released to address temperature management during open heart surgery

The Society of Thoracic Surgeons, the Society of Cardiovascular Anesthesiologists, and the American Society of ExtraCorporeal Technology have released a set of clinical practice guidelines to address management of a patient's temperature during open heart surgery. The guidelines appear in the August issue of The Annals of Thoracic Surgery and were published simultaneously in two other journals. [More]
OBP Medical introduces CLEAR-TRAC family of disposable surgical retractors

OBP Medical introduces CLEAR-TRAC family of disposable surgical retractors

OBP Medical, the leading global developer of single-use, self-contained, illuminating medical devices, today announced the launch of its CLEAR-TRAC family of disposable surgical retractors. The line—which includes CLEAR-TRAC SP (surgical pocket), CLEAR-TRAC V (vaginal) and new CLEAR-TRAC B (breast)—is the first on the market to offer a built-in, single-use light source. [More]
Statins benefit patients undergoing major lung resection, lower major complications

Statins benefit patients undergoing major lung resection, lower major complications

Statins have been shown to reduce complications from cardiovascular surgery. To determine whether statins might also help those undergoing major lung surgeries, a team at Memorial Sloan Kettering Cancer Center conducted a well-designed study that randomized patients to receive either a statin or placebo before and after surgery. [More]
Implantable antibiotic-laden sponges help prevent sternal wound infections during cardiac surgery

Implantable antibiotic-laden sponges help prevent sternal wound infections during cardiac surgery

Cardiac surgeons often "crack open" the flat bone that forms the middle front section of the chest, known as the sternum, in order to reach important structures. When a sternal wound infection (SWI) occurs, serious complications and even death may result. Implanting antibiotic-laden sponges between the sternal halves before closure has been adapted to prevent infections. [More]
Dr. Oz expands partnership with iHeartMedia

Dr. Oz expands partnership with iHeartMedia

The Dr. Oz Show and iHeartMedia announced today they have expanded their partnership, increasing Dr. Oz's robust radio presence across iHeartMedia broadcast radio stations and on iHeartRadio, the all-in-one digital music and streaming radio service. [More]
Withholding ARBs for longer than two days after surgery significantly increases risk of postoperative death

Withholding ARBs for longer than two days after surgery significantly increases risk of postoperative death

Withholding angiotensin receptor blockers (ARBs) for longer than two days after surgery is associated with a significantly increased risk of postoperative death, according to a study of more than 30,000 patients in the VA health care system by researchers at UC San Francisco and the San Francisco VA Medical Center. [More]
New research draws on support from patients and public to investigate impact of cardiac surgery

New research draws on support from patients and public to investigate impact of cardiac surgery

A University of Leicester-based research group funded by the British Heart Foundation is drawing on support from patients and members of the public to investigate why cardiac surgery can often result in serious or fatal damage to other organs in the body. [More]
Astute Medical's NephroCheck Test obtains measurements of two biomarkers that act as alarm for AKI risk

Astute Medical's NephroCheck Test obtains measurements of two biomarkers that act as alarm for AKI risk

An intervention known as remote ischemic preconditioning (RIPC) significantly reduced the occurrence of acute kidney injury (AKI) in cardiac surgery patients and confirmed that post-operative elevations of two kidney biomarkers act as an alarm for risk of AKI, according to a study published online today in the Journal of the American Medical Association. [More]
CSL Behring awarded NHF's 2015 Corporate Leadership Award

CSL Behring awarded NHF's 2015 Corporate Leadership Award

The National Hemophilia Foundation has awarded CSL Behring its 2015 Corporate Leadership Award as recognition for the company's longstanding and unwavering commitment to advancing science and improving the care of the bleeding disorders community. The award was accepted by Paul Perreault, CEO and Managing Director, CSL Limited, during the NHF Annual Spring Soiree in New York City on May 21. [More]
Post-operative atrial fibrillation can significantly increase risk of heart attack or stroke

Post-operative atrial fibrillation can significantly increase risk of heart attack or stroke

As many as 12 percent of patients undergoing major, non-cardiac surgery experience an irregular heartbeat called atrial fibrillation. [More]
Certain metabolites in the blood could predict clinical outcome in children undergoing heart surgery

Certain metabolites in the blood could predict clinical outcome in children undergoing heart surgery

The study, published today in the journal Critical Care Medicine and carried out at Royal Brompton Hospital, followed children undergoing surgery for congenital heart disease, and found that by analysing metabolites in the blood -- molecules created as a result of metabolism -- it was possible to predict a child's clinical outcome. [More]
Use of fresh whole blood from single donors may reduce complications in pediatric heart surgery patients

Use of fresh whole blood from single donors may reduce complications in pediatric heart surgery patients

Using fresh whole blood from single donors is better than using component blood from multiple donors in pediatric heart surgery patients, according to an article in the May 2015 issue of The Annals of Thoracic Surgery. [More]
Young age and small body weight predispose pediatric CHD patients toward re-intervention

Young age and small body weight predispose pediatric CHD patients toward re-intervention

A retrospective review of 633 adults and children who underwent bioprosthetic pulmonary valve replacement (PVR) for congenital heart disease between 1996 and 2014 indicated that the risk of re-intervention was five times greater for children than adults, with the likelihood of re-intervention decreasing by 10% for each increasing year of age at surgery. [More]
Getinge secures EUR 160 million loan from EIB for development of new medical devices

Getinge secures EUR 160 million loan from EIB for development of new medical devices

The European Investment Bank has provided a EUR 160 million loan to Getinge AB, a global medical technology company, for its research and development in the areas of surgery, intensive care, infection control, care ergonomics and wound care. Getinge’s research addresses unmet medical needs and targets the development of new devices with higher efficiency and safety for increased positive outcomes for both caregivers and patients. [More]
Advertisement
Advertisement